abstract |
The present invention is directed to adoptive immune effector cell therapy for the treatment, prevention or amelioration of a number of pathologies including but not limited to cancer, infectious diseases, autoimmune diseases, inflammatory diseases and immunodeficiencies. Provided is an improved composition. [Selected figure] FIG. |